STOCK TITAN
  1. Home
  2. SEC Filings
  3. VICR
  4. [144] VICOR CORP SEC Filing

VICR selling holders report multiple 10b5-1 sales

VICR proposed resales of Common Stock under Rule 144 by multiple holders, primarily reported as systematic 10b5-1 sales by Patrizio Vinciarelli.

Filing Impact
(Neutral)
Filing Sentiment

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment worksHow the balance works

Form Type
144

Rhea-AI Filing Summary

VICR proposed resales of Common Stock under Rule 144 by multiple holders, primarily reported as systematic 10b5-1 sales by Patrizio Vinciarelli.

The excerpt lists repeated dispositions of 20,000 shares on multiple dates in June 2026 and larger single-day blocks of 50,000 shares in April–March 2026. Several institutional entries (Brigham and Womens Hospital; Lahey Hospital & Medical Center) appear for 3,500 shares each.

Insights

Routine, pre-arranged insider dispositions using 10b5-1 plans are reported; no new allegations or corporate actions shown.

The excerpt catalogues multiple 10b5-1 sales by a named individual with repeating daily blocks of $6,097,442.00 and similar totals tied to June 2026 trades. These entries read as execution-level resale notices rather than corporate financing or issuer-directed sales.

Future filings may show additional notices; timing and cash-flow recipients are the selling holders per the entries. The filings do not disclose outstanding share context or proceeds treatment beyond per-trade amounts in the excerpt.

Representative daily sale 20,000 shares multiple dates in <date>June 2026</date> attributed to 10b5-1 sales
Trade proceeds example <money>$6,097,442.00</money> sale of <b>20,000 shares</b> on <date>06/12/2026</date>
Larger single-day block 50,000 shares reported on multiple dates in <date>March–April 2026</date>
Institutional sale example 3,500 shares Brigham and Women's Hospital on <date>05/14/2026</date>
Dollar amount for 3,500-share trade <money>$1,043,623.00</money> Brigham and Women's Hospital sale on <date>05/14/2026</date>
10b5-1 regulatory
"10b5-1 Sales for PATRIZIO VINCIARELLI 25 Frontage Road"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Founders Shares financial
"Common | 11/10/1981 | Founders Shares | Issuer"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
Issuer regulatory
"Founders Shares | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider sales are reported for VICR in this Form 144 excerpt?
The excerpt reports repeated 10b5-1 sales by Patrizio Vinciarelli and others, including multiple 20,000-share trades in June 2026 and several 50,000-share blocks earlier in 2026.

Did any institutions appear as sellers in the VICR excerpt?
Yes. The excerpt lists Brigham and Women's Hospital and Lahey Hospital & Medical Center, each with reported sales of 3,500 shares on May 14, 2026.

Are the dollar amounts shown for each sale in the excerpt?
Yes. Each line includes a trade-level dollar figure, for example $6,097,442.00 for a 20,000-share sale on 06/12/2026, as provided in the excerpt.

Does the excerpt state who receives proceeds from these sales?
The excerpt attributes the trades to the selling holders (e.g., Patrizio Vinciarelli, listed institutions). It does not state any issuer receipt of proceeds in the provided lines.

Are these sales described as occurring under a trading plan?
Yes. Many entries are labeled explicitly as 10b5-1 Sales, indicating execution under pre-arranged trading plans as shown in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Accepted by SEC EDGAR

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

Keep reading

More on VICR

All VICR news

Trending in the feed

LQDA
Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics, Ensuring Continued Commercialization of YUTREPIA in PAH Open the live feed